Canopy Growth Corp Research And Development Expense
Canopy Growth Corp (CGC) reported Research And Development Expense of CAD 15.24 million for the 12-month period ending 2019-03-31, per its 40-F filed 2019-06-26.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2019-06-26
| Period end | Research And Development Expense 12 month |
|---|---|
| 2019-03-31 | 15.24M CAD 40-F · filed 2019-06-26 |
| 2018-03-31 | 1.45M CAD 40-F · filed 2019-06-26 |
| 2017-03-31 | 810.00K CAD 40-F · filed 2018-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |